16- to 25-year follow-up study of cemented arthroplasty of the hip in patients aged 50 years or younger

Devitt, Aiden; O’Sullivan, T; Quinlan, W.

doi:10.1016/s0883-5403(97)90169-8

Cited by 76 publications

(34 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Survival rate at 15 years was 88.1% for the femoral implants (95% confidence interval; range, 75%-100%) and 74.5% for the acetabular implants (95% confidence interval; mean, 59.1%-89.9%). The average Merle d'Aubigné-Postel score was 17.4 ± 1 (range, [13][14][15][16][17][18] Fig. 2 This graph depicts the distribution of intraoperative complications.…”

Section: Resultsmentioning

confidence: 99%

Alumina-on-Alumina Hip Arthroplasty in Patients Younger Than 30 Years Old

Nizard

Pourreyron

Raould

et al. 2008

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

THA in patients younger than 30 years old presents challenges: the initial technical challenge relates to the initial disease that often causes deformities making reconstruction difficult, while the long-term challenge is wear and subsequent osteolysis and component loosening. Ceramic-on-ceramic prostheses may represent a valuable option to reduce wear. We retrospectively studied 101 patients (132 hips) with ceramic-on-ceramic prostheses implanted from 1977 to 2004. As a result of the long span of time, different implant designs and modes of fixation were used. The average age of the patients was 23.4 ± 5 years (range, 13-30 years), and the main indication for THA was femoral head necrosis. The minimum followup was 1 year (mean, 6.9 years; range, 1-26.5 years). We documented 17 revisions (13%) for aseptic loosening. Twelve were for isolated acetabular loosening, two for isolated femoral loosening, and three for loosening of both components. Survivorship was 82.1% at 10 years and 72.4% at 15 years. Inferior survivorship was observed for THA performed after secondary arthritis related to slipped capital epiphysis or trauma. Limited osteolysis was observed in one hip. The main limiting factor in this series was the fixation of the acetabular component. However, improvements in the design and in the mode of fixation of this component should enhance long-term results.

show abstract

Section: Resultsmentioning

confidence: 99%

Alumina-on-Alumina Hip Arthroplasty in Patients Younger Than 30 Years Old

Nizard

Pourreyron

Raould

et al. 2008

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

show abstract

“…Many previous studies have demonstrated inferior survival and clinical performance of other cemented THAs when used in patients younger than 50 years [2,6,7,13,17,20,40,47]. One of the reported reasons for stem failure is the quality of cementation [3].…”

Section: Introductionmentioning

confidence: 99%

The Exeter™ Universal Hip in Patients 50 Years or Younger at 10-17 Years' Followup

Lewthwaite

Squires

Gie

et al. 2008

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

The Exeter TM Universal hip (Stryker Inc., Newbury, UK) has reported survival rates of 91.74% at 12 years in all patients with reoperation as an endpoint. However, its performance in younger patients has not been fully established. We reviewed survivorship and the clinical and radiographic outcomes of this hip system implanted in 107 patients (130 hips) 50 years old or younger at the time of surgery. The mean age at surgery was 42 years. The minimum followup was 10 years (mean, 12.5 years; range, 10-17 years) with no patients lost to followup. Twelve hips had been revised. Of these, nine had aseptic loosening of the acetabular component and one cup was revised for focal lysis and pain. One hip was revised for recurrent dislocation and one joint underwent revision for infection. Radiographs demonstrated 14 (12.8%) of the remaining acetabular prostheses were loose but no femoral components were loose. Survivorship of both stem and cup from all causes was 92.6% at an average of 12.5 years. Survivorship of the stem from all causes was 99% and no stem was revised for aseptic loosening. The Exeter TM

show abstract

“…This is because our database is comparable to a joint registry and radiographic information is not recorded. Our centre does however collect annual hip scores, and postoperative clinical scores have shown strong correlation with radiographic loosening following total hip replacement [8,38]. We propose that future studies should try to include radiographic outcomes for follow-up of hip arthroplasty in patients with rheumatoid arthritis.…”

Section: Discussionmentioning

confidence: 99%

Hip resurfacing for rheumatoid arthritis: independent assessment of 11-year results from an international register

Aulakh

Kuiper

Dixey

et al. 2010

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

Total hip replacement has shown good outcomes for patients with rheumatoid arthritis. Can hip resurfacing give similar results for patients with rheumatoid arthritis? Using an international hip resurfacing register, 47 patients with rheumatoid arthritis were identified and age and gender matched to a group of 131 randomly selected patients with osteoarthritis of the hip joint. Patients completed a questionnaire to record function and implant revision. Hierarchical regression, Cox regression and Kaplan-Meier method were used for analysis. There was a significant increase in post operative hip score in both groups (p<0.001) with rheumatoid group scoring higher as compared to the osteoarthritis group (p=0.23). The post operative score was not significantly influenced by pre-operative score and age (p=0.15 and 0.84, respectively) but the preoperative score was a predictor of implant failure (p=0.02). Patient mobility was affected by age with younger patients scoring high on mobility as compared to older patients (p= 0.01). The Kaplan-Meier analysis showed a survival rate of 96.3% in the rheumatoid group and 97.8% in the osteoarthritis group. This difference was not significant (Log rank test, p=0.45). Our results from an independent and international register show that hip resurfacing provides good postoperative hip function and excellent implant survival for patients with rheumatoid arthritis of the hip joint. This procedure can be considered as a viable option for management of rheumatoid arthritis of the hip joint.

show abstract

16- to 25-year follow-up study of cemented arthroplasty of the hip in patients aged 50 years or younger

Cited by 76 publications

References 40 publications

Alumina-on-Alumina Hip Arthroplasty in Patients Younger Than 30 Years Old

Alumina-on-Alumina Hip Arthroplasty in Patients Younger Than 30 Years Old

The Exeter™ Universal Hip in Patients 50 Years or Younger at 10-17 Years' Followup

Hip resurfacing for rheumatoid arthritis: independent assessment of 11-year results from an international register

Contact Info

Product

Resources

About